Tirzepatide (Mounjaro): Tirzepatide is a newer GLP-1 receptor agonist that has shown promise in both diabetes management and weight loss
These medications regulate blood sugar, promote fullness, and support weight loss by mimicking hormones that stimulate insulin release
Maintain regular sleep: Poor sleep causes fatigue and makes nausea harder to manage
#wegovy #novonordisk To view or add a comment, sign in FDA Approval Update | Obesity Medicine The FDA has approved once-daily oral Wegovy (semaglutide) for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, as an adjunct to diet and physical activity
Additionally studies on zinc supplementation found reductions in body weight, but only when combined with a calorie-restricted diet
Khoo J, Hsiang JC, Taneja R et al (2019) Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease
